<s> The Food and Drug Administration said American Home Products Corp. agreed to recall certain generic drugs that were produced by its Quantum Pharmics unit in Amityville , N.Y . </s>
<s> Quantum stopped shipping the drugs last month , following a federal investigation regarding information the company supplied to obtain three drug approvals . </s>
<s> The FDA requested the recall of Quantum 's mioxidil tablets , chlorazepate dipotassium tablets and meclofenamate sodium capsules because , it said , the size of the production runs submitted for testing to gain FDA approval was in each case misrepresented as much larger than it actually was . </s>
<s> American Home Products , based in New York , agreed to recall four other products , trazadone , doxepin , diazepam and lorazapam , because of concerns about data submitted in their original approval applications before the FDA . </s>
<s> No safety problems with the products are known , the FDA said . </s>
<s> An FDA spokesperson said the drugs are still available under other brand names . </s>
<s> Last month , American Home Products said it was suspending production and distribution of all 21 of Quantum 's generic drug products pending the completion of an exhaustive internal audit . </s>
<s> It also temporarily closed Quantum , because of the internal investigation , as well as the FDA 's ongoing inquiry . </s>
<s> In New York Stock Exchange composite trading , American Home Products rose 75 cents to $ 105 on Friday . </s>
